Defining rules for cancer cell proliferation in TRAIL stimulation

NPJ Systems Biology and Applications
William DeveauxKumar Selvarajoo

Abstract

Owing to their self-organizing evolutionary plasticity, cancers remain evasive to modern treatment strategies. Previously, for sensitizing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant human fibrosarcoma (HT1080), we developed and validated a dynamic computational model that showed the inhibition of protein kinase (PK)C, using bisindolylmaleimide (BIS) I, enhances apoptosis with 95% cell death. Although promising, the long-term effect of remaining ~ 5% cells is a mystery. Will they remain unchanged or are they able to proliferate? To address this question, here we adopted a discrete spatiotemporal cellular automata model utilizing simple rules modified from the famous "Conway's game of life". Based on three experimental initializations: cell numbers obtained from untreated (high), treatment with TRAIL only (moderate), and treatment with TRAIL and BIS I (low), the simulations show cell proliferation in time and space. Notably, when all cells are fixed in their initial space, the proliferation is rapid for high and moderate cell numbers, however, slow and steady for low number of cells. However, when mesenchymal-like random movement was introduced, the proliferation becomes significant even for low cel...Continue Reading

References

Jan 7, 1993·Journal of Theoretical Biology·G B Ermentrout, L Edelstein-Keshet
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Oct 18, 2005·The Journal of Biological Chemistry·Eugene VarfolomeevAvi Ashkenazi
Jun 26, 2007·Cells, Tissues, Organs·Christine L ChafferElizabeth D Williams
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Jan 26, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Melissa G MendezRobert D Goldman
Jun 4, 2011·Cellular and Molecular Life Sciences : CMLS·Arun Satelli, Shulin Li
Feb 23, 2012·Scientific Reports·Vincent PirasKumar Selvarajoo
Apr 24, 2013·Methods : a Companion to Methods in Enzymology·Markus Rehm, Jochen H M Prehn
Aug 7, 2013·Interface Focus·Philip K MainiS Seirin Lee
Nov 10, 2013·Cell Communication and Signaling : CCS·Kentaro HayashiKumar Selvarajoo
Sep 4, 2014·Journal of Biological Engineering·Kumar Selvarajoo
Jan 21, 2015·Frontiers in Immunology·Kentaro HayashiKumar Selvarajoo
Jul 15, 2015·Nature Reviews. Cancer·Amy BrockDonald E Ingber
Sep 12, 2015·Journal of Cancer Research and Clinical Oncology·Jie ZhangYu Jiang
Nov 13, 2015·Current Cancer Drug Targets·Yasumichi InoueHidetoshi Hayashi
Nov 10, 2017·Methods in Molecular Biology·Kumar Selvarajoo

❮ Previous
Next ❯

Software Mentioned

Conway
Cytell
matlab
Cytell cell imaging system

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.